How can we harness our inner human potential to effectively address the growing complexity of our environment and the global challenges that impact our business? This was the theme at our annual company day, where Sarah Emond (Director,...
Read MoreRed Glead is exhibiting at Discovery on Target (DOT) Boston, 25-28th of September (booth #201). The event covers advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutics....
Read MoreRed Glead Discovery AB, which recently received Lund municipality’s Business Award for 2023, has signed an agreement with Medicon Village that ensures possibilities for continued expansion over the next 10 years. “The agreement is an important step in our...
Read MoreFacilitating knowledge exchange and networking for experts in peptide science The Öresund Peptide Symposium is held for the fourth time since its start. The program for this year will bring together industry leaders and researchers within peptide drug discovery and green peptide...
Read MoreThe award is given annually to a company in Lund that is working with global challenges of the future, that is innovative and that is recognised as a good ambassador for the municipality. “We are incredibly grateful for...
Read MoreWe are delighted to share the news of the recent success of Aqilion, who secured an exclusive license and strategic research collaboration with Merck. The deal is worth up to EUR 950 million for their pre-clinical TAK1 inhibitor program....
Read MoreFive times during the last six years, Red Glead Discovery AB has been recognized as a Gasell company by Scandinavia’s largest business paper, Dagens Industri. The award is given annually to fast-growing and profitable Swedish companies with sound finances...
Read MoreEvaluation of gold-based compounds as Plasmodium falciparum aquaglyceroporin inhibitors An extensive cross-disciplinary study involving computational chemistry, synthesis and in vitro testing returned promising insights on the application of metal complexes for the treatment of drug-resistant malaria. During the investigation,...
Read MoreLund, Sweden August 30th, 2022 Red Glead Discovery has set emissions reduction targets through the Science Based Targets initiative (SBTi), with levels required to meet the goals of the Paris Agreement. Red Glead Discovery has now...
Read MoreCopenhagen, Denmark and Lund, Sweden February 22nd, 2022 In this unique strategic partnership, Desupervised and Red Glead Discovery join forces to create robust AI-based solutions enabling companies to reduce cost and time in small molecule drug research and...
Read More